This year’s Life Science Tennessee Annual Conference and Venture Forum will take a deep dive into how Tennessee’s life science technologies are improving Tennessee’s economic outlook, as well as the general health and well-being of all.
The conference will feature some of the top life science executives, thought leaders and legislative supporters of the industry in two full days of keynote speakers, industry subsector breakout panels and a pitch competition for promising early stage Tennessee life science companies.
The University of Alabama will host the 2nd NanoBio Summit on October 23-24, 2014 at the Bryant Conference Center, located on the campus of the University of Alabama in Tuscaloosa, Alabama. The Summit will provide a scientific forum for industry professionals, faculty, students, and postdoctoral scholars from a broad range of disciplines including biology, chemistry, physics, engineering, materials science, and medicine.
General areas of focus at the Summit include: nanobioscience, nanoengineering, nanomaterials, collaboration, discovery and commercialization. The Summit will provide opportunities to accelerate new research and academic collaborations while targeting the latest research findings, innovations, and implementations of nanotechnology.
Device manufacturers, biodesign innovators, regulatory specialists, and academics register now for the 2nd Annual UGA Medical Device Regulations Conference! This conference, cosponsored by the US FDA and the University of Georgia’s Office of BioPharma Regulatory Affairs, will provide educational and networking opportunities to help shape the future of medical device advancement from a regulatory science perspective.
Using a tutorial approach, experienced leaders from the FDA, industry, and consulting firms will present and engage the audience on issues related to strategic implications of FDA device regulations.
This conference has been accredited for 6 hours of Regulatory Affairs Continuing Education credit.
Device manufacturers, biodesign innovators, regulatory specialists, and academics are invited to the 2nd annual UGA Medical Device Regulations Conference! This conference, cosponsored by the US FDA and the University of Georgia’s Office of BioPharma Regulatory Affairs, will provide educational and networking opportunities to help shape the future of medical device advancement from a regulatory science perspective.
Registration and more information forthcoming.
The Southeast BIO (SEBIO) Investor & Partnering Forum provides an unparalleled opportunity for companies to meet key decision makers in the regional and national life science and medical technology communities.
Over 16 years, the SEBIO Investor & Partnering Forum has built a loyal following, attracting thought leaders and investors from across the country. We expect another sensational event in 2014 that will provide new opportunities to build business partnerships and explore the region’s burgeoning life science industry.
We expect about 350 biotech and medtech investors, corporate executives, university representatives, entrepreneurs and service providers to attend the event. This is a perfect opportunity to showcase your company’s products and services at the most significant annual life science event in the Southeast.
To date, the more than 200 later stage and 165 early stage companies that participated in previous SEBIO Investor & Partnering Forums have raised more than $2.5 billion in public and private funding since their presentations. These numbers speak to the quality of our presenting companies. In addition, our BIO/Plan Competition has successfully mentored 65 emerging technology opportunities.
Georgia’s life sciences community is a rich mix of companies applying life sciences technologies to improve medicine and healthcare, agriculture, industrial and energy production, forestry, marine science and environmental management. These companies range from established to start-up and from pharmaceutical to medical device and diagnostic to medical informatics companies. The state’s life sciences industry is anchored by world-class public and private research institutions and universities, including Emory University, the Georgia Institute of Technology and the University of Georgia. The U.S. Centers for Disease Control and Prevention, the premier public health research institute in the world, is headquartered in Atlanta. Georgia’s state government, through the Georgia Research Alliance and Georgia Cancer Coalition, has invested hundreds of millions of dollars in the state’s universities to support scientists in pursuit of basic research discoveries and early commercialization of technologies. These factors combined with a business-friendly environment provide a comprehensive ecosystem for life sciences companies to thrive in Georgia.
For more information and to register, please visit the conference site.
The North Carolina Biotechnology Center’s AgBiotech Initiative and North Carolina State University’s College of Agriculture and Life Sciences are combining their signature events for this two-day conference. This event will engage the agriculture and biotechnology communities to address key topics such as research innovation, technology commercialization, regulation, policy, public acceptance, agricultural production, and ag biotech products. Experts will discuss challenges and opportunities related to bringing products to market while ensuring a safe and abundant food supply for a growing world.
Early-Bird Registration is open!! Limited time $59.00
The University of Florida ranks among the nation’s leaders at transferring world-class research to partners who turn these discoveries into commercial products that make the world a better place. If you are an investor, entrepreneur or other interested party who has the resources needed to partner with us, we hope you will join us at A Celebration of Innovation, UF’s eighth annual startup showcase, on March 10, 2015.
A Celebration of Innovation is a unique opportunity to see startup companies commercializing the latest life science, medical device, and cutting-edge technologies generated as a result of the more than $640 million in research conducted annually at UF. Those interested in licensing, commercializing, investing or otherwise becoming involved with getting new discoveries to the marketplace will want to mark their calendars to attend.
Check back for the agenda; information about panelists and presenting companies will be posted when available.
For further information and to register, please click here.